Search

Your search keyword '"Ware, James H."' showing total 181 results
Start Over Author "Ware, James H." Search Limiters Full Text
181 results on '"Ware, James H."'

3. Effect of intratrial mean 25(OH)D concentration on diabetes risk, by race and weight: an ancillary analysis in the D2d randomized study cohort

Author

Chatterjee, Ranee, primary, Davenport, Clemontina A., additional, Vickery, Ellen M., additional, Johnson, Karen C., additional, Kashyap, Sangeeta R., additional, LeBlanc, Erin S., additional, Nelson, Jason, additional, Dagogo-Jack, Samuel, additional, Pittas, Anastassios G., additional, Hughes, Bess Dawson, additional, Brodsky, Irwin, additional, Ceglia, Lisa, additional, Chadha, Chhavi, additional, Chatterjee, Ranee, additional, Dawson-Hughes, Bess, additional, Desouza, Cyrus, additional, Dolor, Rowena, additional, Foreyt, John, additional, Ghazi, Adline, additional, Hsia, Daniel S., additional, Kim, Sun, additional, Lewis, Michael R., additional, Liao, Emilia, additional, Malozowski, Saul, additional, Neff, Lisa M., additional, O’Neil, Patrick, additional, Park, Jean, additional, Peters, Anne, additional, Phillips, Lawrence S., additional, Pratley, Richard, additional, Raskin, Philip, additional, Rasouli, Neda, additional, Robbins, David, additional, Rosen, Clifford, additional, Aroda, Vanita R., additional, Sheehan, Patricia, additional, Staten, Myrlene A., additional, Ware, James H., additional, and Knowler, William C., additional

Published
2023
Full Text
View/download PDF

6. Effects of Lead Exposure

Author

Ernhart, Claire B., Rogan, Walter J., Ware, James H., Dietrich, Kim N., Radcliffe, Jerilynn, and Rhoads, George G.

Published
2001

10. Large lipid-rich coronary plaques detected by near-infrared spectroscopy at non-stented sites in the target artery identify patients likely to experience future major adverse cardiovascular events

Author

Madder, Ryan D., Husaini, Mustafa, Davis, Alan T., VanOosterhout, Stacie, Khan, Mohsin, Wohns, David, McNamara, Richard F., Wolschleger, Kevin, Gribar, John, Collins, J. Stewart, Jacoby, Mark, Decker, Jeffrey M., Hendricks, Michael, Sum, Stephen T., Madden, Sean, Ware, James H., and Muller, James E.

Published
2016
Full Text
View/download PDF

34. Influence of Timing of Clopidogrel Treatment on the Efficacy and Safety of Bivalirudin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Author

Lincoff, A. Michael, Steinhubl, Steven R., Manoukian, Steven V., Chew, Derek, Pollack, Charles V., Jr, Feit, Frederick, Ware, James H., Bertrand, Michel E., Ohman, E. Magnus, Desmet, Walter, Cox, David A., Mehran, Roxana, and Stone, Gregg W.

Published
2008
Full Text
View/download PDF

37. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial

Author

Mehran, Roxana, Pocock, Stuart J., Stone, Gregg W., Clayton, Tim C., Dangas, George D., Feit, Frederick, Manoukian, Steven V., Nikolsky, Eugenia, Lansky, Alexandra J., Kirtane, Ajay, White, Harvey D., Colombo, Antonio, Ware, James H., Moses, Jeffrey W., and Ohman, E Magnus

Published
2009

38. Geographical Inequalities and Social and Environmental Risk Factors for Under-Five Mortality in Ghana in 2000 and 2010: Bayesian Spatial Analysis of Census Data

Author

Arku, Raphael E., Bennett, James E., Castro, Marcia C., Agyeman-Duah, Kofi, Mintah, Samilia E., Ware, James H., Nyarko, Philomena, Spengler, John D., Agyei-Mensah, Samuel, and Ezzati, Majid

Subjects
Mortality -- Risk factors -- Analysis -- Ghana, Children -- Health aspects, Equality -- Demographic aspects -- Social aspects -- Environmental aspects, Biological sciences
Abstract

Background Under-five mortality is declining in Ghana and many other countries. Very few studies have measured under-five mortality-and its social and environmental risk factors-at fine spatial resolutions, which is relevant for policy purposes. Our aim was to estimate under-five mortality and its social and environmental risk factors at the district level in Ghana. Methods and Findings We used 10% random samples of Ghana's 2000 and 2010 National Population and Housing Censuses. We applied indirect demographic methods and a Bayesian spatial model to the information on total number of children ever born and children surviving to estimate under-five mortality (probability of dying by 5 y of age, 5q0) for each of Ghana's 110 districts. We also used the census data to estimate the distributions of households or persons in each district in terms of fuel used for cooking, sanitation facility, drinking water source, and parental education. Median district 5q0 declined from 99 deaths per 1,000 live births in 2000 to 70 in 2010. The decline ranged from 40% in southern districts, where it had been lower in 2000, exacerbating existing inequalities. Primary education increased in men and women, and more households had access to improved water and sanitation and cleaner cooking fuels. Higher use of liquefied petroleum gas for cooking was associated with lower 5q0 in multivariate analysis. Conclusions Under-five mortality has declined in all of Ghana's districts, but the cross-district inequality in mortality has increased. There is a need for additional data, including on healthcare, and additional environmental and socioeconomic measurements, to understand the reasons for the variations in mortality levels and trends., Author(s): Raphael E. Arku 1, James E. Bennett 2,3, Marcia C. Castro 4, Kofi Agyeman-Duah 5, Samilia E. Mintah 5, James H. Ware 6, Philomena Nyarko 5, John D. Spengler [...]

Published
2016
Full Text
View/download PDF

43. Bivalirudin for Patients with Acute Coronary Syndromes

Author

Stone, Gregg W, McLaurin, Brent T, Cox, David A, Bertrand, Michel E, Lincoff, A Michael, Moses, Jeffrey W, White, Harvey D, Pocock, Stuart J, Ware, James H, Feit, Frederick, Colombo, Antonio, Aylward, Philip E, Cequier, Angel R, Darius, Harald, Desmet, Walter, Ebrahimi, Ramin, Hamon, Martial, Rasmussen, Lars H, Rupprecht, Hans-Jürgen, Hoekstra, James, Mehran, Roxana, Ohman, E Magnus, ACUITY Investigators, and Universitat de Barcelona

Subjects
Male, Coronary, Myocardial Ischemia, Kaplan-Meier Estimate, Gastroenterology, Angina, Coronary diseases, 80 and over, Bivalirudin, Angioplasty, Balloon, Coronary, Coronary Artery Bypass, Aged, 80 and over, Medicine (all), Anticoagulant, Antithrombin, General Medicine, Heparin, Hirudins, Middle Aged, Recombinant Proteins, Adult, Aged, Angina, Unstable, Anticoagulants, Drug Therapy, Combination, Enoxaparin, Female, Hemorrhage, Humans, Peptide Fragments, Platelet Glycoprotein GPIIb-IIIa Complex, Combination, Cardiology, medicine.drug, medicine.medical_specialty, Bypass cardiopulmonary, medicine.drug_class, Heparina, Ischemia, Malalties coronàries, Unstable, Drug Therapy, Internal medicine, medicine, business.industry, Angioplasty, medicine.disease, Bypass cardiopulmonar, Glycoprotein IIb/IIIa inhibitors, Relative risk, Anticoagulants (Medicina), Anticoagulants (Medicine), business, Balloon
Abstract

BACKGROUND: Current guidelines for patients with moderate- or high-risk acute coronary syndromes recommend an early invasive approach with concomitant antithrombotic therapy, including aspirin, clopidogrel, unfractionated or low-molecular-weight heparin, and glycoprotein IIb/IIIa inhibitors. We evaluated the role of thrombin-specific anticoagulation with bivalirudin in such patients. METHODS: We assigned 13,819 patients with acute coronary syndromes to one of three antithrombotic regimens: unfractionated heparin or enoxaparin plus a glycoprotein IIb/IIIa inhibitor, bivalirudin plus a glycoprotein IIb/IIIa inhibitor, or bivalirudin alone. The primary end points were a composite ischemia end point (death, myocardial infarction, or unplanned revascularization for ischemia), major bleeding, and the net clinical outcome, defined as the combination of composite ischemia or major bleeding. RESULTS: Bivalirudin plus a glycoprotein IIb/IIIa inhibitor, as compared with heparin plus a glycoprotein IIb/IIIa inhibitor, was associated with noninferior 30-day rates of the composite ischemia end point (7.7% and 7.3%, respectively), major bleeding (5.3% and 5.7%), and the net clinical outcome end point (11.8% and 11.7%). Bivalirudin alone, as compared with heparin plus a glycoprotein IIb/IIIa inhibitor, was associated with a noninferior rate of the composite ischemia end point (7.8% and 7.3%, respectively; P=0.32; relative risk, 1.08; 95% confidence interval [CI], 0.93 to 1.24) and significantly reduced rates of major bleeding (3.0% vs. 5.7%; P

Published
2006

46. Comment

Author

Rogan, Walter J. and Ware, James H.

Subjects
Error analysis (Mathematics) -- Models, Regression analysis -- Models, Mathematics
Abstract

An article on the application of auxiliary information in correcting omitted-variables bias is evaluated. The approach was used to generate bias-corrected estimates of data from four studies on the effects of lead exposure to children's IQ. However, it is argued that the authors of the article should have applied to approach on five prospective studies on the subject because of the additional information these provide., This article considers a transportation network in which nodes are connected by directed links. By going from node to node, various 'trips' may be constructed. The goal is to infer [...]

Published
1998

47. Outcomes Following Pre-Operative Clopidogrel Administration in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery

Author

Ebrahimi, Ramin, primary, Dyke, Cornelius, additional, Mehran, Roxana, additional, Manoukian, Steven V., additional, Feit, Frederick, additional, Cox, David A., additional, Gersh, Bernard J., additional, Ohman, E. Magnus, additional, White, Harvey D., additional, Moses, Jeffrey W., additional, Ware, James H., additional, Lincoff, A. Michael, additional, and Stone, Gregg W., additional

Published
2009
Full Text
View/download PDF

48. Optimizing Trial Design

Author

Mehta, Cyrus, primary, Gao, Ping, additional, Bhatt, Deepak L., additional, Harrington, Robert A., additional, Skerjanec, Simona, additional, and Ware, James H., additional

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results